Skip to content

Drug interactions

Lenacapavir + Tofacitinib

Severity: Moderate

Lenacapavir and Tofacitinib: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Lenacapavir is a moderate CYP3A4 inhibitor, and its long-acting subcutaneous form can have effects lasting for months after dosing. Tofacitinib levels may rise modestly, increasing the risk of dose-related adverse effects.

What this interaction means in plain words

Lenacapavir and Tofacitinib can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Lenacapavir belongs to Anti Virals; Tofacitinib belongs to Musculoskeletal.

Evidence level: Low

Why it happens

Inhibition of CYP3A4 reduces tofacitinib metabolism.

What to do

No routine dose change is needed; monitor for infection and cytopenias, including for months after the last lenacapavir injection.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Lenacapavir and Tofacitinib, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Lenacapavir with Tofacitinib?

MediHelp rates the interaction as moderate. Lenacapavir and Tofacitinib can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Lenacapavir is a moderate CYP3A4 inhibitor, and its long-acting subcutaneous form can have effects lasting for months after dosing. Tofacitinib levels may rise modestly, increasing the risk of dose-related adverse effects.

How serious is the interaction between Lenacapavir and Tofacitinib?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: No routine dose change is needed; monitor for infection and cytopenias, including for months after the last lenacapavir injection.

What other medicines interact with Tofacitinib?

MediHelp also lists interactions of Tofacitinib with, for example, Baricitinib, Cladribine, Upadacitinib. The full list is on the Tofacitinib page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in